BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25752615)

  • 1. Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool.
    Shantsila E; Wolff A; Lip GY; Lane DA
    Int J Clin Pract; 2015 Aug; 69(8):840-5. PubMed ID: 25752615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
    Shantsila E; Wolff A; Lip GY; Lane DA
    Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of advanced age on management and prognosis in atrial fibrillation: insights from a population-based study in general practice.
    Wolff A; Shantsila E; Lip GY; Lane DA
    Age Ageing; 2015 Sep; 44(5):874-8. PubMed ID: 26082176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project.
    Fauchier L; Lecoq C; Clementy N; Bernard A; Angoulvant D; Ivanes F; Babuty D; Lip GY
    Chest; 2016 Apr; 149(4):960-8. PubMed ID: 26425935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.
    McGrath ER; Go AS; Chang Y; Borowsky LH; Fang MC; Reynolds K; Singer DE
    J Am Geriatr Soc; 2017 Feb; 65(2):241-248. PubMed ID: 28039855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do CHA2 DS2 VASc and HAS-BLED scores influence 'real-world' anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre.
    Lopatowska P; Tomaszuk-Kazberuk A; Mlodawska E; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S; Musial WJ
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1297-303. PubMed ID: 26419506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry.
    Li YG; Miyazawa K; Wolff A; Zubaid M; Alsheikh-Ali AA; Sulaiman K; Lip GYH
    Int J Cardiol; 2019 Jan; 274():158-162. PubMed ID: 30291008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients.
    Wilke T; Groth A; Mueller S; Pfannkuche M; Verheyen F; Linder R; Maywald U; Kohlmann T; Feng YS; Breithardt G; Bauersachs R
    Thromb Haemost; 2012 Jun; 107(6):1053-65. PubMed ID: 22398417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inadequate oral anticoagulation with warfarin in women with cerebrovascular event and history of atrial fibrillation: the FibStroke study.
    Bah A; Nuotio I; Palomäki A; Mustonen P; Kiviniemi T; Ylitalo A; Hartikainen P; Airaksinen KEJ; Hartikainen JEK
    Ann Med; 2021 Dec; 53(1):287-294. PubMed ID: 33475002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of atrial fibrillation in a geographically well-defined population in northern Sweden: implications for anticoagulation prophylaxis.
    Andersson P; Löndahl M; Abdon NJ; Terent A
    J Intern Med; 2012 Aug; 272(2):170-6. PubMed ID: 22250988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.
    Lip GY; Rushton-Smith SK; Goldhaber SZ; Fitzmaurice DA; Mantovani LG; Goto S; Haas S; Bassand JP; Camm AJ; Ambrosio G; Janský P; Al Mahmeed W; Oh S; van Eickels M; Raatikainen P; Steffel J; Oto A; Kayani G; Accetta G; Kakkar AK;
    Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S12-20. PubMed ID: 25714828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
    Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
    Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke.
    Baturova MA; Lindgren A; Carlson J; Shubik YV; Bertil Olsson S; Platonov PG
    Int J Cardiol; 2017 Apr; 232():134-139. PubMed ID: 28132778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation: The Chinese Atrial Fibrillation Registry Study.
    Chang SS; Dong JZ; Ma CS; Du X; Wu JH; Tang RB; Xia SJ; Guo XY; Yu RH; Long DY; Bai R; Liu N; Sang CH; Jiang CX; Liu XH; Pan JH; Lip GY
    Stroke; 2016 Jul; 47(7):1803-10. PubMed ID: 27283198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of atrial fibrillation: a retrospective review of patients presenting to acute medical services.
    Jolliffe E; Fu V; Lanford J; Weatherall M; Rosemergy I
    Intern Med J; 2016 Oct; 46(10):1166-1171. PubMed ID: 27501863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in Use of Anticoagulation in Patients With Atrial Fibrillation Within a Primary Care Network Associated With the Introduction of Direct Oral Anticoagulants.
    Ashburner JM; Singer DE; Lubitz SA; Borowsky LH; Atlas SJ
    Am J Cardiol; 2017 Sep; 120(5):786-791. PubMed ID: 28693744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with oral anticoagulant drugs restrained from patients with atrial fibrillation: An assessment in a geographically well-defined catchment area.
    Andersson P; Löndahl M
    Eur J Prev Cardiol; 2016 Sep; 23(13):1437-43. PubMed ID: 26976847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.
    Lee SI; Sayers M; Lip GY; Lane DA
    Int J Clin Pract; 2015 Nov; 69(11):1341-8. PubMed ID: 26234557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality after ground-level fall in the elderly patient taking oral anticoagulation for atrial fibrillation/flutter: a long-term analysis of risk versus benefit.
    Inui TS; Parina R; Chang DC; Inui TS; Coimbra R
    J Trauma Acute Care Surg; 2014 Mar; 76(3):642-9; discussion 649-50. PubMed ID: 24553530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.